The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


GlaxoSmithKline Dungarvan LimitedEU/1/07/401/1-6

Main Information

Trade NameAlli
Active SubstancesOrlistat
Dosage FormCapsule, hard
Licence HolderGlaxoSmithKline Dungarvan Limited
Licence NumberEU/1/07/401/1-6

Group Information

ATC CodeA08AB Peripherally acting antiobesity products
A08AB01 orlistat


License statusAuthorised
Licence Issued
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back